Part 7/8:

However, being part of the clinical trial offers a strategic advantage: if trials commence before the tide of a second wave hits Singapore, researchers could obtain early data on vaccine efficacy. This could lead to quicker conclusions about the vaccine’s protective ability and, ultimately, faster access for the public.

The Silver Lining

Although the prospect of a resurgence is daunting, early trial data could prove invaluable. If the vaccine demonstrates effectiveness in the upcoming wave, it could dramatically influence public health responses and save many lives. Such developments underscore the importance of ongoing research and international collaboration in combatting COVID-19.